PATENT CLAIM ANALYSIS

Application Number: 16254163
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["424", "001890"]

Abstract:
A method for detecting or ruling out renal amyloidosis in a subject is disclosed. The use of a stilbene derivative, such as florbetapir  18 F, or a phenylbenzothiazole derivative in positron emission tomography imaging, or integrated positron emission tomography/computed tomography imaging, can serve as a screening test for renal amyloidosis in a subject.

Claim (Index 6):
The method of  claim 1  wherein:\n step (b) comprises acquiring the image using positron emission tomography with computed tomography imaging.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.59459
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13878689', '15030214', '12064146', '15320112', '15748556']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7306073078979857
- 35 USC 102 Novelty (BERT): 0.4847394814991518
- Combined Prediction Score: 0.7060205252581022
- Mean Citation Score: 224.64024
- Max Citation Score: 262.05453
- Similarity Product: 252.6751853972966

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test